Annual EBITDA
-$1.36 M
+$2.55 M+65.21%
31 December 2023
Summary:
Nephros annual earnings before interest, taxes, depreciation & amortization is currently -$1.36 million, with the most recent change of +$2.55 million (+65.21%) on 31 December 2023. During the last 3 years, it has risen by +$2.85 million (+67.70%). NEPH annual EBITDA is now -111.48% below its all-time high of $11.84 million, reached on 31 December 2007.NEPH EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly EBITDA
$217.00 K
+$471.00 K+185.43%
01 September 2024
Summary:
Nephros quarterly earnings before interest, taxes, depreciation & amortization is currently $217.00 thousand, with the most recent change of +$471.00 thousand (+185.43%) on 01 September 2024. Over the past year, it has increased by +$343.00 thousand (+272.22%). NEPH quarterly EBITDA is now -98.68% below its all-time high of $16.46 million, reached on 31 December 2007.NEPH Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM EBITDA
-$773.00 K
+$343.00 K+30.73%
01 September 2024
Summary:
Nephros TTM earnings before interest, taxes, depreciation & amortization is currently -$773.00 thousand, with the most recent change of +$343.00 thousand (+30.73%) on 01 September 2024. Over the past year, it has increased by +$643.00 thousand (+45.41%). NEPH TTM EBITDA is now -106.51% below its all-time high of $11.88 million, reached on 31 December 2007.NEPH TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
NEPH EBITDA Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +65.2% | +272.2% | +45.4% |
| 3 y3 years | +67.7% | +129.4% | +73.9% |
| 5 y5 years | +55.9% | +133.5% | +77.5% |
NEPH EBITDA High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +67.7% | at high | +114.8% | at high | +80.2% |
| 5 y | 5 years | at high | +67.7% | at high | +113.8% | at high | +81.6% |
| alltime | all time | -111.5% | +82.3% | -98.7% | +104.1% | -106.5% | +89.9% |
Nephros EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $217.00 K(-185.4%) | -$773.00 K(-30.7%) |
| June 2024 | - | -$254.00 K(+89.6%) | -$1.12 M(-10.1%) |
| Mar 2024 | - | -$134.00 K(-77.7%) | -$1.24 M(-8.6%) |
| Dec 2023 | -$1.36 M(-65.2%) | -$602.00 K(+377.8%) | -$1.36 M(-4.1%) |
| Sept 2023 | - | -$126.00 K(-66.8%) | -$1.42 M(-41.9%) |
| June 2023 | - | -$379.00 K(+51.0%) | -$2.44 M(-9.6%) |
| Mar 2023 | - | -$251.00 K(-62.0%) | -$2.69 M(-31.0%) |
| Dec 2022 | -$3.91 M(+56.8%) | -$660.00 K(-42.4%) | -$3.90 M(+0.8%) |
| Sept 2022 | - | -$1.15 M(+79.9%) | -$3.87 M(+11.7%) |
| June 2022 | - | -$637.00 K(-56.4%) | -$3.47 M(-10.9%) |
| Mar 2022 | - | -$1.46 M(+132.8%) | -$3.89 M(+34.2%) |
| Dec 2021 | -$2.49 M(-40.8%) | -$628.00 K(-15.0%) | -$2.90 M(-2.1%) |
| Sept 2021 | - | -$739.00 K(-30.2%) | -$2.96 M(-6.3%) |
| June 2021 | - | -$1.06 M(+124.8%) | -$3.16 M(-14.1%) |
| Mar 2021 | - | -$471.00 K(-31.7%) | -$3.67 M(-12.7%) |
| Dec 2020 | -$4.21 M(+39.8%) | -$690.00 K(-26.4%) | -$4.21 M(+11.2%) |
| Sept 2020 | - | -$937.00 K(-40.5%) | -$3.78 M(+8.3%) |
| June 2020 | - | -$1.58 M(+56.8%) | -$3.50 M(+26.5%) |
| Mar 2020 | - | -$1.00 M(+277.8%) | -$2.76 M(-8.2%) |
| Dec 2019 | -$3.01 M(-2.4%) | -$266.00 K(-59.0%) | -$3.01 M(-12.4%) |
| Sept 2019 | - | -$648.00 K(-23.2%) | -$3.43 M(+5.3%) |
| June 2019 | - | -$844.00 K(-32.5%) | -$3.26 M(+7.6%) |
| Mar 2019 | - | -$1.25 M(+81.0%) | -$3.03 M(-1.7%) |
| Dec 2018 | -$3.08 M(+48.4%) | -$691.00 K(+45.2%) | -$3.08 M(+11.4%) |
| Sept 2018 | - | -$476.00 K(-22.5%) | -$2.77 M(-0.3%) |
| June 2018 | - | -$614.00 K(-52.8%) | -$2.78 M(-1.7%) |
| Mar 2018 | - | -$1.30 M(+246.3%) | -$2.82 M(+36.0%) |
| Dec 2017 | -$2.08 M(-21.0%) | -$376.00 K(-22.3%) | -$2.08 M(-7.0%) |
| Sept 2017 | - | -$484.00 K(-26.9%) | -$2.23 M(+0.4%) |
| June 2017 | - | -$662.00 K(+19.3%) | -$2.23 M(-3.8%) |
| Mar 2017 | - | -$555.00 K(+4.1%) | -$2.31 M(-8.4%) |
| Dec 2016 | -$2.63 M(-7.2%) | -$533.00 K(+12.0%) | -$2.52 M(-6.6%) |
| Sept 2016 | - | -$476.00 K(-36.4%) | -$2.70 M(-1.6%) |
| June 2016 | - | -$749.00 K(-2.3%) | -$2.75 M(-26.8%) |
| Mar 2016 | - | -$767.00 K(+7.7%) | -$3.75 M(+40.1%) |
| Dec 2015 | -$2.83 M(-57.5%) | -$712.00 K(+37.2%) | -$2.68 M(-9.3%) |
| Sept 2015 | - | -$519.00 K(-70.4%) | -$2.95 M(-817.8%) |
| June 2015 | - | -$1.75 M(-671.0%) | $411.00 K(-113.2%) |
| Mar 2015 | - | $307.00 K(-131.2%) | -$3.10 M(-53.5%) |
| Dec 2014 | -$6.67 M | -$985.00 K(-134.7%) | -$6.67 M(+294.1%) |
| Sept 2014 | - | $2.84 M(-154.0%) | -$1.69 M(-66.0%) |
| June 2014 | - | -$5.27 M(+61.5%) | -$4.98 M(+1564.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2014 | - | -$3.26 M(-181.7%) | -$299.00 K(-116.6%) |
| Dec 2013 | $1.90 M(-160.9%) | $3.99 M(-1003.6%) | $1.80 M(-157.2%) |
| Sept 2013 | - | -$442.00 K(-25.0%) | -$3.15 M(-10.2%) |
| June 2013 | - | -$589.00 K(-49.4%) | -$3.51 M(-3.4%) |
| Mar 2013 | - | -$1.16 M(+22.0%) | -$3.63 M(+20.1%) |
| Dec 2012 | -$3.11 M(+37.8%) | -$953.00 K(+19.0%) | -$3.02 M(+10.8%) |
| Sept 2012 | - | -$801.00 K(+12.5%) | -$2.73 M(+17.1%) |
| June 2012 | - | -$712.00 K(+28.3%) | -$2.33 M(+6.3%) |
| Mar 2012 | - | -$555.00 K(-15.8%) | -$2.19 M(-3.0%) |
| Dec 2011 | -$2.26 M(+28.2%) | -$659.00 K(+63.9%) | -$2.26 M(+4.0%) |
| Sept 2011 | - | -$402.00 K(-30.0%) | -$2.17 M(+1.8%) |
| June 2011 | - | -$574.00 K(-7.7%) | -$2.13 M(+12.7%) |
| Mar 2011 | - | -$622.00 K(+8.6%) | -$1.89 M(+7.4%) |
| Dec 2010 | -$1.76 M(-19.1%) | -$573.00 K(+57.9%) | -$1.76 M(+5.1%) |
| Sept 2010 | - | -$363.00 K(+8.7%) | -$1.68 M(-7.0%) |
| June 2010 | - | -$334.00 K(-32.0%) | -$1.80 M(-9.8%) |
| Mar 2010 | - | -$491.00 K(+0.6%) | -$2.00 M(-8.1%) |
| Dec 2009 | -$2.17 M(-65.3%) | -$488.00 K(-0.4%) | -$2.17 M(-10.6%) |
| Sept 2009 | - | -$490.00 K(-7.4%) | -$2.43 M(-24.8%) |
| June 2009 | - | -$529.00 K(-20.8%) | -$3.23 M(-38.2%) |
| Mar 2009 | - | -$668.00 K(-10.6%) | -$5.24 M(-16.2%) |
| Dec 2008 | -$6.27 M(-153.0%) | -$747.00 K(-42.1%) | -$6.25 M(-157.1%) |
| Sept 2008 | - | -$1.29 M(-49.0%) | $10.95 M(+3.8%) |
| June 2008 | - | -$2.53 M(+50.4%) | $10.55 M(-9.2%) |
| Mar 2008 | - | -$1.68 M(-110.2%) | $11.62 M(-2.2%) |
| Dec 2007 | $11.84 M(-254.1%) | $16.46 M(-1071.1%) | $11.88 M(-277.7%) |
| Sept 2007 | - | -$1.70 M(+16.2%) | -$6.68 M(-2.0%) |
| June 2007 | - | -$1.46 M(+2.2%) | -$6.82 M(-8.7%) |
| Mar 2007 | - | -$1.43 M(-32.1%) | -$7.47 M(-2.8%) |
| Dec 2006 | -$7.68 M(+27.6%) | -$2.10 M(+14.8%) | -$7.68 M(+2.8%) |
| Sept 2006 | - | -$1.83 M(-13.0%) | -$7.48 M(+102.8%) |
| June 2006 | - | -$2.11 M(+28.3%) | -$3.69 M(+2.6%) |
| Mar 2006 | - | -$1.64 M(-13.5%) | -$3.59 M(+54.4%) |
| Dec 2005 | -$6.02 M(-19.2%) | -$1.90 M(-196.9%) | -$2.33 M(-3.6%) |
| Sept 2005 | - | $1.96 M(-197.2%) | -$2.41 M(-61.1%) |
| June 2005 | - | -$2.01 M(+436.7%) | -$6.21 M(+5.7%) |
| Mar 2005 | - | -$375.10 K(-81.1%) | -$5.87 M(+6.8%) |
| Dec 2004 | -$7.45 M(+71.2%) | -$1.98 M(+8.2%) | -$5.50 M(+56.5%) |
| Sept 2004 | - | -$1.83 M(+9.1%) | -$3.51 M(+109.1%) |
| June 2004 | - | -$1.68 M | -$1.68 M |
| Dec 2003 | -$4.35 M(+442.2%) | - | - |
| Dec 2002 | -$802.20 K(+83.2%) | - | - |
| Dec 2001 | -$437.90 K | - | - |
FAQ
- What is Nephros annual earnings before interest, taxes, depreciation & amortization?
- What is the all time high annual EBITDA for Nephros?
- What is Nephros annual EBITDA year-on-year change?
- What is Nephros quarterly earnings before interest, taxes, depreciation & amortization?
- What is the all time high quarterly EBITDA for Nephros?
- What is Nephros quarterly EBITDA year-on-year change?
- What is Nephros TTM earnings before interest, taxes, depreciation & amortization?
- What is the all time high TTM EBITDA for Nephros?
- What is Nephros TTM EBITDA year-on-year change?
What is Nephros annual earnings before interest, taxes, depreciation & amortization?
The current annual EBITDA of NEPH is -$1.36 M
What is the all time high annual EBITDA for Nephros?
Nephros all-time high annual earnings before interest, taxes, depreciation & amortization is $11.84 M
What is Nephros annual EBITDA year-on-year change?
Over the past year, NEPH annual earnings before interest, taxes, depreciation & amortization has changed by +$2.55 M (+65.21%)
What is Nephros quarterly earnings before interest, taxes, depreciation & amortization?
The current quarterly EBITDA of NEPH is $217.00 K
What is the all time high quarterly EBITDA for Nephros?
Nephros all-time high quarterly earnings before interest, taxes, depreciation & amortization is $16.46 M
What is Nephros quarterly EBITDA year-on-year change?
Over the past year, NEPH quarterly earnings before interest, taxes, depreciation & amortization has changed by +$343.00 K (+272.22%)
What is Nephros TTM earnings before interest, taxes, depreciation & amortization?
The current TTM EBITDA of NEPH is -$773.00 K
What is the all time high TTM EBITDA for Nephros?
Nephros all-time high TTM earnings before interest, taxes, depreciation & amortization is $11.88 M
What is Nephros TTM EBITDA year-on-year change?
Over the past year, NEPH TTM earnings before interest, taxes, depreciation & amortization has changed by +$643.00 K (+45.41%)